Order results by:
Issue | Title | |
Vol 16, No 5 (2020) | COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II) | Abstract similar documents |
O. V. Blagova, N. V. Varionchik, M. M. Beraia, V. A. Zaidenov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup | ||
"... . The interaction of chronic myocarditis and COVID-19 during long-term immunosuppressive therapy has not been ..." | ||
Vol 16, No 4 (2020) | COVID-19 Pneumonia in Patients with Chronic Myocarditis (Recurrent Infectious Immune): Specifics of the Diseases Course, the Role of Basic Therapy (Part 1) | Abstract similar documents |
O. V. Blagova, N. V. Varionchik, M. M. Beraia, V. A. Zaidenov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup | ||
"... as immunosuppressive therapy. At the same time, the features of the interaction of chronic myocarditis and COVID-19 ..." | ||
Vol 10, No 2 (2014) | CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment) | Abstract similar documents |
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova | ||
"... study infectious-immune myocarditis was found in 78.9% patients with IA and 66.7% patients with DCM ..." | ||
Vol 17, No 5 (2021) | Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias | Abstract similar documents |
O. V. Blagova, A. V. Nedostup, E. A. Kogan | ||
"... (n=3) infectious immune myocarditis; parvovirus-positive endomyocarditis (n=1); undifferentiated ..." | ||
Vol 21, No 1 (2025) | Successful treatment of acute inflammatory cardiomyopathy in a young patient with COVID-19: a clinical case | Abstract similar documents |
O. V. Soldatova, I. Ya. Goryanskaya | ||
"... Myocardial injury in COronaVIrus Disease 2019 (COVID-19) mainly occurs in young and middle-aged ..." | ||
Vol 20, No 4 (2024) | Prevalence of chronic myocarditis in patients with atrial fibrillation according to the results of a single-center study | Abstract similar documents |
E. A. Archakov, R. E. Batalov, M. S. Khlynin, M. A. Dragunova, E. S. Sitkova, O. R. Eshmatov, T. V. Moskovskikh, S. Yu. Usenkov, I. V. Stepanov, S. A. Afanasyev, S. V. Popov | ||
"... Aim. To assess the incidence of chronic myocarditis in patients with atrial fibrillation ..." | ||
Vol 10, No 1 (2014) | CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics) | Abstract similar documents |
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova | ||
"... study infectious-immune myocarditis was found in 78.9% of IA and 66.7% of DCM-patients, arrhythmogenic ..." | ||
Vol 14, No 5 (2018) | Clinical Case: Tuberculous Myopericarditis in the Cardiology Practice | Abstract similar documents |
A. I. Skripka, A. V. Buchneva, V. V. Vankhin, N. V. Lisyanskaya, V. V. Babyre, P. V. Senchikhin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
Vol 15, No 4 (2019) | Syndrome of Primary Myocardial Hypertrophy: Clinical and Morphological, Genetic Diagnostics and Comparison of Sarcomerial Variants of Cardiomyopathy and its Phenocopy | Abstract similar documents |
O. V. Blagova, E. V. Zaklyazminskaya, E. A. Kogan, V. P. Sedov, G. М. Radzhabova, M. Е. Polyak, A. V. Nedostup | ||
"... of ejection fraction (EF) (55.7±12.5% vs 62.5±10.1% in HCM, p=0.08). The morphologic signs of myocarditis were ..." | ||
Vol 19, No 6 (2023) | Potential for intramyocardial fibrosis detection based on estimation of extracellular volume using dual-energy computed tomography | Abstract similar documents |
E. A. Mershina, D. A. Filatova, M. V. Lisitskaya, E. V. Ryzhkova, R. P. Myasnikov, V. E. Sinitsyn | ||
Vol 20, No 2 (2024) | Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements | Abstract similar documents |
L. D. Khidirova, A. E. Latsvieva, A. V. Vederin | ||
"... сердечно-с осудистой системы, вызывая изменения как воспалительной (миокардит, перикардит, коронарный ..." | ||
Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... At the end of 2020, a new term “post-COVID-19 syndrome” appeared in the medical community ..." | ||
Vol 11, No 6 (2015) | The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities | Abstract similar documents |
E. A. Mershina, R. P. Myasnikov, O. V. Kulikova, M. S. Kharlap, S. N. Koretskiy, O. M. Larina, V. E. Sinitsyn, S. A. Boytsov | ||
"... . The sudden decompensation of NCLVC also could arise due to the development of acute myocarditis ..." | ||
Vol 20, No 1 (2024) | Acute myocardial infarction-like event in a young patient with biventricular arrhythmogenic cardiomyopathy | Abstract similar documents |
Y. V. Stavtseva, E. A. Mershina, T. V. Lobzhanidze, E. I. Bazdireva, N. I. Khutsishvili, Zh. D. Kobalava | ||
"... with MI and acute myocarditis in patients with elevated troponin and nonobstructive coronary arteries. ..." | ||
Vol 14, No 5 (2018) | Myocardial Infarction with Nonobstructive Coronary Arteries (МINОСА) – a Trendy Term or a New Diagnostic Concept? | Abstract similar documents |
S. S. Yakushin | ||
"... ) and non-coronary reasons, caused by cardiac (cardiomyopathy, myocarditis) and non-cardiac (pulmonary ..." | ||
Vol 14, No 5 (2018) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis | Abstract similar documents |
D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova | ||
"... direct damage to the myocardium and coronary arteries (myocarditis, coronary vasculitis, microcirculatory ..." | ||
Vol 14, No 6 (2018) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part II): Difficulties of Diagnosis | Abstract PDF (Eng) similar documents |
D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova | ||
"... and T2 regimens, in the diagnosis of myocarditis, myocardial fibrosis, and myocardial perfusion ..." | ||
Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
"... underwent COVID-19. Material and methods. Hypertensive patients with dyslipidemia who underwent COVID-19 [n ..." | ||
Vol 19, No 1 (2023) | Acute Coronary Syndrome during the Pandemic New Coronavirus Infection | Abstract similar documents |
O. M. Drapkina, A. Ya. Kravchenko, A. V. Budnevskiy, A. V. Kontsevaya, E. S. Ovsyannikov, E. S. Drobysheva | ||
"... The experience of managing patients with COVID-19 around the world has shown that, although ..." | ||
Vol 19, No 1 (2023) | Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study | Abstract PDF (Eng) similar documents |
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina | ||
"... of Coronavirus disease 2019 (COVID-19). Material and Methods. This retrospective cohort study involved adult ..." | ||
Vol 17, No 6 (2021) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
"... that 341 (20.8%) patients with COVID-19 were diagnosed with sinus tachycardia, which required ..." | ||
Vol 18, No 2 (2022) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
"... defects, rheumatic heart damage, acute coronary syndrome, endocarditis, myocarditis, pericarditis ..." | ||
Vol 18, No 1 (2022) | Noncompact Myocardium with Dilated Phenotype: Manifestations, Treatment and Outcomes in Comparison with Other Forms of Dilated Cardiomyopathy Syndrome | Abstract PDF (Eng) similar documents |
O. V. Blagova, E. V. Pavlenko, N. V. Varionchik, V. P. Sedov, N. V. Gagarina, E. A. Mershina, M. E. Polyak, E. V. Zaklyazminskaya, A. V. Nedostup | ||
"... =15) had NCM diagnosed simultaneously with acute/subacute myocarditis. Lethality in these subgroups ..." | ||
Vol 17, No 2 (2021) | Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasil'eva, E. P. Batrakova, N. V. Lobova, E. E. Bykova, M. M. Khachuroeva | ||
"... . The data on such a manifestation of post-COVID syndrome as postural orthostatic tachycardia syndrome (POTS ..." | ||
Vol 18, No 4 (2022) | Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels | Abstract PDF (Eng) similar documents |
O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov | ||
"... died with COVID-19, to access the correlation between anticoagulation therapy (ACT) and thrombotic ..." | ||
Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
"... Aim. To assess long-term sequelae of COVID-19 in hospitalized patients at 3 to 7 months after ..." | ||
Vol 18, No 2 (2022) | Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome | Abstract similar documents |
E. L. Trisvetova | ||
"... and persisted for 3-6 months after recovery. The term "post-COVID-19syndrome" has appeared, reflecting ..." | ||
Vol 18, No 4 (2022) | Impact of the COVID-19 Pandemic on Myocardial Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation | Abstract PDF (Eng) similar documents |
B. G. Alekyan, S. A. Boytsov, V. I. Ganyukov, E. M. Manoshkina | ||
"... infection (COVID-19) pandemic (2020-2021). Material and methods. The analysis included the number of cases ..." | ||
Vol 19, No 2 (2023) | sVCAM-1 as a Marker of Endothelial Dysfunction associated with Severe Course of a Novel Coronavirus Infection (COVID-19) | Abstract similar documents |
V. I. Podzolkov, A. E. Pokrovskaya, D. D. Vanina, I. I. Shvedov | ||
"... with the severe course of COVID-19. Material and methods. The study included 100 patients with COVID-19, who were ..." | ||
Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
S. Yu. Martsevich | ||
"... and angiotensin II receptor antagonists (ARA) in patients with COVID-19 is analyzed in the article ..." | ||
Vol 16, No 3 (2020) | Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs | Abstract similar documents |
O. V. Gaisenok | ||
"... This review analyzes existing approaches to the treatment of COVID-19 patients with antimalarial ..." | ||
Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
"... diseases (CVD) and long-term outcomes in post-COVID-19 patients with cardiovascular multimorbidity (CVMM ..." | ||
Vol 17, No 1 (2021) | Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic | Abstract PDF (Eng) similar documents |
S. Y. Martsevich, Y. V. Lukina, E. D. Zharkova, N. P. Kutishenko | ||
"... The new coronavirus infection (COVID-19) pandemic and the subsequent quarantine measures ..." | ||
Vol 17, No 6 (2021) | Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 | Abstract similar documents |
I. S. Yavelov | ||
"... with COVID-19 without additional indication for anticoagulation. Data regarding rate of thrombotic ..." | ||
Vol 20, No 5 (2024) | Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova | ||
"... polymorphism in patients with COronaVIrus Disease 2019 (COVID-19). Material and methods: 100 patients (mean age ..." | ||
Vol 17, No 6 (2021) | Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) | Abstract similar documents |
S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina | ||
"... Aim. Based on the data from the register of patients with COVID-19 and community-acquired ..." | ||
Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
"... , COVID-19) within the framework of the prospective TARGET-VIP registry. Material and methods. 1 ..." | ||
Vol 20, No 4 (2024) | Mural infectious endocarditis in a patient with tetralogy of Fallot: a clinical case | Abstract similar documents |
I. E. Kotlyar, A. E. Filchkova, N. V. Enenkov, A. S. Sidashova, D. O. Kondratyev, N. V. Dobrynina, K. I. Vasyushkina, T. A. Gorokhova | ||
Vol 18, No 6 (2022) | Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study | Abstract similar documents |
F. T. Ageev, M. D. Smirnova | ||
"... , history of novel coronavirus infection (COVID-19) during the previous year was obtained. Also, measurement ..." | ||
Vol 19, No 3 (2023) | Intractable complicated course of tricuspid valve infective endocarditis due to non-compliance of treatment with clinical guidelines with a decisive role of molecular biological study in etiological diagnosis: a case report | Abstract similar documents |
E. O. Kotova, A. Yu. Moiseeva, E. A. Domonova, O. Yu. Silveytrova, A. S. Pisaryuk, P. V. Kakhktsyan, J. I. Babukhina, Zh. D. Kobalava | ||
"... and HIV infection, with a history of a COVID-19 and the development of uncontrolled staphylococcal ..." | ||
Vol 19, No 5 (2023) | Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) | Abstract similar documents |
V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina | ||
"... patients had died. The COVID-19 pandemic did not significantly affect the mortality rates. The most common ..." | ||
1 - 44 of 44 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)